FEB 16, 2021 8:00 AM PST

What Dead Cells Can Tell Us About Our Health

WRITTEN BY: Tara Fernandez

Taking a tissue sample from an organ suspected of harboring a disease is a common diagnostic practice. Instead of relying on living tissue biopsies for answers, could analyzing dead cells be a less invasive, less painful way of understanding what’s going wrong with a patient?

Certain tissues undergo a constant cell turnover whereby some cells die only to be replaced by new ones. Take the skin, for example, where an estimated 40,000 skin cells are shed every day. 

As dying cells reach the end of their shelf lives, their DNA begins to break down into fragments, some of which can end up in the circulatory system. According to researchers, these bits and pieces of DNA, known as cell-free DNA, are rich sources of information about the health of the organs they originated in.

All cells in the body have uniform and identical DNA sequences. However, the way the DNA is packaged and organized in cells derived from different tissues differs significantly. Proteins called histones pack and order DNA into repeated structural units known as nucleosomes. These histones contain chemical barcodes that code information on where the cells came from, their biological function and could even have molecular red flags that point to the presence of disease.

Researchers at Hebrew University have created a “barcode reader” to extract and analyze this epigenetic information from cell-free DNA present in blood samples, potentially putting an end to painful tissue biopsies for good.

“As a result of these scientific advancements, we understood that if this information is maintained within the DNA structure in the blood, we could use that data to determine the tissue source of dead cells and the genes that were active in those very cells,” said Nir Friedman, who led the research published in Nature Biotechnology.

“Based on those findings, we can uncover key details about the patient’s health.”

According to Friedman, these details include why a particular cell died, what disease a patient has and how the condition is progressing. 

The technique, known as ChIP-seq, was validated in blood samples taken from a cohort of nearly 270 participants. ChIP-seq successfully detected anomalies in liver cells in patients with liver disease diagnoses. The scientists also picked up activations in cancer-associated genes in patients with metastatic colorectal carcinoma.

“We hope that this approach will allow for earlier diagnosis of disease and help physicians treat patients more effectively,” said Ronen Sadeh, another contributing author of the paper, who added that besides being non-invasive, ChIP-seq is also far cheaper than current diagnostic methods using biopsies.

“Recognizing the potential of this approach and how this technology can be so beneficial for diagnostic and therapeutic purposes, we set up the company Senseera which will be involved with clinical testing in partnership with major pharmaceutical companies with the goal of making this innovative approach available to patients,” said Sadeh.

 

 

Sources: Nature Biotechnology, Hebrew University of Jerusalem.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 14, 2020
Clinical & Molecular DX
STR Genotyping for Human Sample Identification
DEC 14, 2020
STR Genotyping for Human Sample Identification
Human sample identification is an essential element of many research projects employing human cells, tissues, or mixture ...
DEC 08, 2020
Clinical & Molecular DX
"Honey, I Shrunk the PCR."
DEC 08, 2020
"Honey, I Shrunk the PCR."
In the 1530s, hundreds of years before microscopes and Petri dishes, an Italian physician called Girolamo Fracastoro wro ...
DEC 10, 2020
Clinical & Molecular DX
Gut Feeling: Microbiome Reveals Toxic Chemical Exposure in Kids
DEC 10, 2020
Gut Feeling: Microbiome Reveals Toxic Chemical Exposure in Kids
A study by Duke University researchers has revealed that children’s gut microbiomes hold clues as to their possibl ...
DEC 24, 2020
Clinical & Molecular DX
Feeling Unmotivated? It Could Be Dementia.
DEC 24, 2020
Feeling Unmotivated? It Could Be Dementia.
Apathy, characterized by a pronounced lack of enthusiasm, motivation, or interest, is a predictor of the future onset of ...
JAN 12, 2021
Cell & Molecular Biology
Hyperactive Mitochondria Can Fuel Brain Tumors
JAN 12, 2021
Hyperactive Mitochondria Can Fuel Brain Tumors
The most common and deadly form of brain cancer is known as glioblastoma; the median survival time for patients is only ...
FEB 02, 2021
Cardiology
Investigating a Stress Protein's Relation to Heart Failure
FEB 02, 2021
Investigating a Stress Protein's Relation to Heart Failure
As medicine advances, the world’s population gradually becomes older and older. Cardiovascular disease becomes mor ...
Loading Comments...